EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel Modifier Genes Associated With Pain in Cystic Fibrosis: An In Silico Gene Discovery

Anastasia Ward iD, Ramil Mauleon iD, Chee Y Ooi iD, Nedeljka Rosic iD

Human Mutation · 2025

DOI: 10.1155/humu/7570437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Anastasia Ward und 3 weiteren Autor:innen. Beteiligte Einrichtung: Southern Cross University, Faculty of Health, Coolangatta, Queensland, Australia. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pain, Genes, Modifier. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystic fibrosis (CF) is the most common life‐shortening monogenic autosomal recessive disease in Caucasians with diverse and extensive comorbidities. Where the majority of studies have focused on the respiratory and digestive systems, there has been a paucity of research focusing on pain, even though people living with CF have reported a high prevalence and increased severity of pain. Many studies have identified the complex relationship between genotype and phenotype, and growing evidence suggests that the phenotypic variation observed not only depends on the variations in the CF transmembrane conductance regulator ( CFTR ) gene but also on modifier genes. Gene modifiers (GMs) have been reported to affect many organs or systems in CF. However, there have been no studies on how GMs may influence pain. Therefore, this study is aimed at highlighting potential modifier genes that may affect pain perception in CF and possible responses to therapeutics.

Methods

The bioinformatics workflow adopted includes database and literature mining, pathway enrichment analysis, protein–protein interactions evaluation and drug–gene network investigation.

Results

We identified seven potential pain modifiers in CF, including chymotrypsin C ( CTRC ), serine protease inhibitor Kazal‐Type 1 ( SPINK1 ), tumour necrosis factor ( TNF ), ATP‐binding cassette subfamily B Member 1 ( ABCB1 ), protease serine 1 ( PRSS1 ) and transforming growth factor beta 1 ( TGFB1 ) interacting with the CFTR gene. The analysis of the biochemical pathways indicates that signal transduction and the immune system are likely to be involved in pain processes. The specific GMs, TNF and ABCB1 , are found to be within the central hub genes, indicating their potential influence on the pain pathways in CF.

Conclusions

This in silico analysis highlights potential genes and biochemical pathways implicated in pain pathways that could significantly impact pain perception in people living with CF and their response to prescribed therapies. Further functional analyses are needed to include CF participants and provide a physiological relevance on how genetic polymorphisms of identified GMs may impact their pain phenotype or profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPainGenes, ModifierHumansComputational BiologyComputer SimulationCystic Fibrosis Transmembrane Conductance RegulatorPhenotypeProtein Interaction MapsGene Regulatory NetworksGenetic Association StudiesGenetic Predisposition to Disease

Stichwörter der Autor:innen

bioinformaticscystic fibrosisin silicomodifier genespainphenotype

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Southern Cross University, Faculty of Health, Coolangatta, Queensland, Australia.
  • Rice Breeding Innovations, International Rice Research Institute, Los Banos, Laguna, Philippines.
  • Southern Cross University, Faculty of Science and Engineering, Lismore, New South Wales, Australia.
  • Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, Australia.
  • Department of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia.

ORCID-Profile: Anastasia Ward, Ramil Mauleon, Chee Y Ooi, Nedeljka Rosic

Förderung

  • Medical Research Council
  • National Health and Medical Research Council

Zitieren

APA

Ward, A., Mauleon, R., Ooi, C. Y., & Rosic, N. (2025). Identification of Novel Modifier Genes Associated With Pain in Cystic Fibrosis: An In Silico Gene Discovery. Human Mutation. https://doi.org/10.1155/humu/7570437

Vancouver

Ward A, Mauleon R, Ooi CY, Rosic N. Identification of Novel Modifier Genes Associated With Pain in Cystic Fibrosis: An In Silico Gene Discovery. Human Mutation. 2025. doi:10.1155/humu/7570437

BibTeX
@article{Ward2025,
  author = {Ward, Anastasia and Mauleon, Ramil and Ooi, Chee Y and Rosic, Nedeljka},
  title = {Identification of Novel Modifier Genes Associated With Pain in Cystic Fibrosis: An In Silico Gene Discovery},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/7570437}
}
Kostenlos starten →